Cargando…
A Novel Inflammatory Marker in the Follow-up of Moderate-to-Severe Acne Vulgaris Administered Isotretinoin: Systemic Immune-Inflammation Index (SII)
Background: Systemic immune-inflammation index (SII) is calculated by multiplying the neutrophil-lymphocyte ratio (NLR) and the platelet count. In this study, we aimed to investigate the difference of SII and other inflammatory markers in patients with acne vulgaris compared to healthy controls and...
Autores principales: | TURAN, ÇAĞRI, METIN, NURCAN |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medical University Publishing House Craiova
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9289579/ https://www.ncbi.nlm.nih.gov/pubmed/35911945 http://dx.doi.org/10.12865/CHSJ.48.01.09 |
Ejemplares similares
-
Safety and Efficacy of Low-Dose Isotretinoin in the Treatment of Moderate to Severe Acne Vulgaris
por: Rao, Parinitha K, et al.
Publicado: (2014) -
Unexpected Effects of Oral Isotretinoin in Adolescents With Acne Vulgaris
por: Akpolat, Demet
Publicado: (2021) -
Psychiatric and Developmental Effects of Isotretinoin (Retinoid) Treatment for Acne Vulgaris
por: Suuberg, Alessandra
Publicado: (2019) -
Evaluating Depression Among Acne Vulgaris Patients Treated With Isotretinoin
por: Algamdi, Bader N, et al.
Publicado: (2020) -
Comparing the Efficacy of Low Dose and Conventional Dose of Oral Isotretinoin in Treatment of Moderate and Severe Acne Vulgaris
por: Faghihi, Gita, et al.
Publicado: (2017)